Search by Drug Name or NDC

    NDC 00781-3234-34 Glatopa 20 mg/mL Details

    Glatopa 20 mg/mL

    Glatopa is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sandoz Inc. The primary component is GLATIRAMER ACETATE.

    Product Information

    NDC 00781-3234
    Product ID 0781-3234_fe78c284-c0a7-4860-a18d-16398de95e9f
    Associated GPIs 6240003010E520
    GCN Sequence Number 050210
    GCN Sequence Number Description glatiramer acetate SYRINGE 20 MG/ML SUBCUT
    HIC3 H0E
    HIC3 Description AGENTS TO TREAT MULTIPLE SCLEROSIS
    GCN 17178
    HICL Sequence Number 012810
    HICL Sequence Number Description GLATIRAMER ACETATE
    Brand/Generic Generic
    Proprietary Name Glatopa
    Proprietary Name Suffix n/a
    Non-Proprietary Name Glatiramer Acetate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 20
    Active Ingredient Units mg/mL
    Substance Name GLATIRAMER ACETATE
    Labeler Name Sandoz Inc
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA090218
    Listing Certified Through 2024-12-31

    Package

    NDC 00781-3234-34 (00781323434)

    NDC Package Code 0781-3234-34
    Billing NDC 00781323434
    Package 30 BLISTER PACK in 1 CARTON (0781-3234-34) / 1 SYRINGE, GLASS in 1 BLISTER PACK / 1 mL in 1 SYRINGE, GLASS (0781-3234-71)
    Marketing Start Date 2015-06-18
    NDC Exclude Flag N
    Pricing Information N/A